Trials / Completed
CompletedNCT03492541
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
Evaluation of the Clinical Efficacy and Tolerability of SYSTANE Complete in Adult Patients With Dry Eye Disease Following Topical Ocular Use for 4 Weeks: A Multicenter Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical effectiveness and tolerability of SYSTANE® Complete in adult patients with dry eye disease. Fluorescein-stained tear film break-up time (TFBUT) will be evaluated as the primary objective.
Detailed description
Patients will attend 4 scheduled visits: Screening Visit (Day -7 to Day 0), Visit 1/Baseline Visit (Day 1), Visit 2 (Day 14) and Visit 3 (Day 28).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Propylene glycol-based eye drops | Nano-emulsion ocular lubricant |
Timeline
- Start date
- 2018-07-18
- Primary completion
- 2019-04-30
- Completion
- 2019-05-14
- First posted
- 2018-04-10
- Last updated
- 2019-06-12
Locations
5 sites across 3 countries: United States, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03492541. Inclusion in this directory is not an endorsement.